Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Core EPS: $8.98 in FY2025, up 15.0% from a year earlier.
Latest, FY2025
8.98
Period ended Dec 31, 2025
Change on a year earlier
+15.0%
7.81 in FY2024
History
2 years
Since FY2024
Sources
1
Novartis Form 6-K (0001114448-26-000007)
Where the FY2025 figure comes from
“|| Core basic earnings per share (USD) | 2.03 | 1.98 | 3 | 2 | 8.98 | 7.81 | 15 | 17”
Source: Novartis Form 6-K (0001114448-26-000007) ↗
Reported in Form 6-K.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Core EPS (USD/share) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8.98 | +15.0% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2024 | Dec 31, 2024 | 7.81 | – | Novartis Form 6-K (0001114448-26-000007) ↗ |
Breakdown
What makes up core EPS
Cite this data
StockData. (2026). Novartis Core EPS ($), annual FY2024–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/core-eps-basic
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.